Fig. 2

Durability of SARS-CoV-2 infection-induced immunity. a Pie charts showing percentage of participants with SARS-CoV-2 nucleocapsid-specific IgG above (dark blue) and below (light blue) 3000 AU/mL at each visit. b Pie charts showing percentage of participants with SARS-CoV-2 non-spike-specific CD4 + (top panel) and CD8 + (lower panel) T cells above (dark blue) or below (light blue) background response analysed by AIM